Choi, Jennifer
Anderson, Ronald
Blidner, Ada
Cooksley, Tim
Dougan, Michael
Glezerman, Ilya
Ginex, Pamela
Girotra, Monica
Gupta, Dipti
Johnson, Douglas
Shannon, Vickie R.
Suarez-Almazor, Maria
Rapoport, Bernardo L. http://orcid.org/0000-0001-7610-3653
Lacouture, Mario E.
Article History
Received: 24 April 2020
Accepted: 20 August 2020
First Online: 27 August 2020
Compliance with ethical standards
:
: AB, RA, JC, TC, PG, DG, and VRS have no conflict of interest to declare. MD reports grants from Novartis, other fees from Neoleukin Therapeutics, personal fees from Partner Therapeutics, personal fees from Tillotts Pharma, and grants from Genentech, outside the submitted work. MG reports other fees from Bristol Myers Squibb (BMS) and from AstraZeneca, outside the submitted work. IG reports stock ownership from Pfizer Inc. and personal fees from CytomX Inc., outside the submitted work. DBJ reports other fees from Array Biopharma, grants and other from BMS, other from Jansen, grants from Incyte, other from Merck, and other from Novartis, outside the submitted work. In addition, DBJ has a patent co-inventor on use of CTLA-4 agonist for IrAEs pending. ML reports other (royalties) from Legacy Healthcare Services, from Apricity Health, LLC, from Azitra, Inc., from Deciphera, from Galderma Research and Development, from Johnson and Johnson, from NCODA, from Novocure Inc., from Kyowa Kirin, Inc., from Loxo, from Merck Sharp and Dohme Corporation, from Janssen Research & Development, LLC, from Menlo Therapeutics, from Novartis Pharmaceuticals Corporation, from QED Therapeutics, from F. Hoffmann-La Roche AG, from Amgen Inc., from AstraZeneca Pharmceuticals LP, from Genentech Inc., from Seattle Genetics, from Lutris, from Paxman Coolers, from OnQuality Pharmaceuticals Ltd, and from Takeda Millenium, outside the submitted work. BLR reports personal fees and other from Merck and Co.; grants, personal fees, and other from BMS; grants, personal fees, and other from Roche South Africa; and personal fees and other fees from AstraZeneca, during the conduct of the study. MSA reports personal fees from Gilead, grants from Pfizer, and personal fees from Abbvie, outside the submitted work. All work with these entities has ended.